Results 131 to 140 of about 506,500 (333)
Genotype identification of the Human Papilloma Virus in cervicouterine lesions carrier patients
Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2016 Background: during the last years there has been a high prevalence of women infected with genotypes of the human papilloma virus, considered as a high risk because of its high oncogenicity.Objective: to identify the genotypes of the human papilloma virus
Alexander Morales Fontaine +3 more
doaj
Attitudes towards Human Papilloma Virus Vaccination in the Latin American Andean Region [PDF]
, 2017 Oroma Nwanodi
openalex +1 more source
Bee products as alternatives in the treatment of viral infections
Journal of the Science of Food and Agriculture, Volume 106, Issue 1, Page 33-54, 15 January 2026.Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba +3 more
wiley +1 more source
Human papilloma virus (HPV) molecular diagnostics
Clinical Chemistry and Laboratory Medicine, 2011 Human Papilloma Virus (HPV) is becoming a menace worldwide, especially to the developing world, due to its involvement in a variety of malignancies, with cervical cancer being the most important and prevalent. There are many HPV types; HPV 16/18 are the most carcinogenic but few others are also characterized as high-risk (HR).
Kroupis, Christos, Vourlidis, Nikolaos
openaire +3 more sources
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
Педиатрическая фармакология, 2011 The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination.
E.V. Uvarova, Z.Kh. Kumykova
doaj +2 more sources
European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions
Molecular Oncology, Volume 20, Issue 1, Page 96-116, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts +18 more
wiley +1 more source
Oral human papilloma virus infection among dental clinic attendees in Ibadan, Nigeria
, 2022 Adedayo Omotayo Faneye +4 more
openalex +2 more sources
International Journal of Molecular Sciences, 2017 Most research providing evidence for the role of oncogenic viruses in head and neck squamous cell carcinoma (SCC) development is focused on one type of virus without analyzing possible interactions between two or more types of viruses.
B. Drop +3 more
semanticscholar +1 more source
Using systems thinking to guide the dissemination of the European code against cancer, 5th edition
Molecular Oncology, Volume 20, Issue 1, Page 170-187, January 2026.Knowledge mobilisation is vital for cancer prevention. Using systems thinking, three substudies engaged stakeholders to identify effective strategies to disseminate the European Code Against Cancer, 5th edition (ECAC5). Stakeholders mapped barriers and facilitators and proposed actions focused on collaboration, accessible communication channels and ...
Erica D'Souza +4 more
wiley +1 more source
Human Papilloma Virus Vaccination: Should it be Mandatory?
Journal of Nepal Medical Association, 2008 Cervical cancer is the second most common malignancy and a leading killer among women worldwide. Seventy percent of these cervical cancers are known to be caused by Human Papilloma Virus, which is transmitted primarily by sexual contact. The use of Human
Siru Prasai
doaj +1 more source